Furthermore, a cancer-specific mouse–dog chimeric anti-PDPN antibody (P38Bf) originating from mouse monoclonal PMab-38 were shown to reduce immunological reactions, and P38Bf demonstrated strong anti-tumor effects in a PDPN-overexpressed CHO-K1 cell xenograft mouse model [36,37]. Here, PDPN is linked to cancer.